{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Treg cell", "cytokines", "microRNAs", "multiple sclerosis", "oxygen-ozone therapy", "transcription factor"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33724614", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "06"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "03", "Day": "26"}], "ELocationID": ["10.1002/cbin.11589"], "Journal": {"ISSN": "1095-8355", "JournalIssue": {"Volume": "45", "Issue": "7", "PubDate": {"Year": "2021", "Month": "Jul"}}, "Title": "Cell biology international", "ISOAbbreviation": "Cell Biol Int"}, "ArticleTitle": "The effects of oxygen-ozone therapy on regulatory T-cell responses in multiple sclerosis patients.", "Pagination": {"StartPage": "1498", "EndPage": "1509", "MedlinePgn": "1498-1509"}, "Abstract": {"AbstractText": ["Multiple sclerosis (MS) is a common degenerative disorder of the central nervous system. The decreased frequency and dysfunction of Treg cells cause inflammation and disease progression. Ozone autohemotherapy can be used as a potential therapeutic approach to regulate the immune system responses and inflammation in MS. For this purpose, 20 relapsing-remitting multiple sclerosis patients were under treatment with ozone twice weekly for 6 months. The frequency of Treg cell, the expression levels of the Treg cell-related factors (FoxP3, IL-10, TGF-\u03b2, miR-17, miR-27, and miR-146A), and the secretion levels of IL-10 and TGF-\u03b2 were assessed. We found a significant increase in the number of Treg cells, expression levels of FoxP3, miRNAs (miR-17 and miR-27), IL-10, and TGF-\u03b2 factors in patients after oxygen-ozone (O<sub>2</sub> -O<sub>3</sub> ) therapy compared to before treatment. In contrast, oxygen-ozone therapy notably decreased the expression level of miR-146a in treated patients. Interestingly, the secretion levels of both IL-10 and TGF-\u03b2 cytokines were considerably increased in both serum and supernatant of cultured peripheral blood mononuclear cells in posttreatment condition compared to pretreatment condition. According to results, oxygen-ozone therapy raised the frequency of Treg cell and its relevant factors in treated MS patients. Oxygen-ozone therapy would contribute to improving the MS patients by elevating the Treg cell responses."], "CopyrightInformation": "\u00a9 2021 International Federation for Cell Biology."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Healthy Faculty, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Tahmasebi", "ForeName": "Safa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Health and Medical Technology, Al-Ayen University, Al-Ayen, Iraq."}], "LastName": "Qasim", "ForeName": "Maytham T", "Initials": "MT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Juridical Sciences, Faculty of Legal Disciplines, Kazan Federal University, Kazan, Russian Federation."}], "LastName": "Krivenkova", "ForeName": "Maria V", "Initials": "MV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russian Federation."}], "LastName": "Zekiy", "ForeName": "Angelina O", "Initials": "AO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russian Federation."}], "LastName": "Thangavelu", "ForeName": "Lakshmi", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India."}], "LastName": "Aravindhan", "ForeName": "Surendar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Izadi", "ForeName": "Morteza", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Jadidi-Niaragh", "ForeName": "Farhad", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ghaebi", "ForeName": "Mahnaz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Aslani", "ForeName": "Saeed", "Initials": "S"}, {"Identifier": ["0000-0002-0044-5961"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Aghebat-Maleki", "ForeName": "Leili", "Initials": "L"}, {"Identifier": ["0000-0003-4787-5261"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Ahmadi", "ForeName": "Majid", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Roshangar", "ForeName": "Leila", "Initials": "L"}], "GrantList": [{"Agency": "Baqiyatallah University of Medical Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Cell Biol Int", "NlmUniqueID": "9307129", "ISSNLinking": "1065-6995"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "S88TT14065", "NameOfSubstance": "Oxygen"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Leukocytes, Mononuclear"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["therapy"], "DescriptorName": "Multiple Sclerosis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxygen"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "T-Lymphocytes, Regulatory"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmadi, M. , Abdolmohammadi-Vahid, S. , Ghaebi, M. , Aghebati-Maleki, L. , Dolati, S. , Farzadi, L. , Ghasemzadeh, A. , Hamdi, K. , Younesi, V. , Nouri, M. , & Yousefi, M. (2017). Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment. Systems Biology in Reproductive Medicine, 63(6), 350-359. https://doi.org/10.1080/19396368.2017.1390007"}, {"Citation": "Ahmadi, M. , Aghdam, S. A. , Nouri, M. , Babaloo, Z. , Farzadi, L. , Ghasemzadeh, A. , Hamdi, K. , Movassaghpour, A. A. , Jadidi-Niaragh, F. , Afkham, A. , Motallebnezhad, M. , Eghbal-Fard, S. , Dolati, S. , Younesi, V. , & Yousefi, M. (2017). Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial. Immunology Letters, 192, 12-19. https://doi.org/10.1016/j.imlet.2017.10.003"}, {"Citation": "Ahmadi, M. , Gharibi, T. , Dolati, S. , Rostamzadeh, D. , Aslani, S. , Baradaran, B. , Younesi, V. , & Yousefi, M. (2017). Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases. Biomedicine & Pharmacotherapy, 87, 596-608."}, {"Citation": "Ahmadi, M. , Yousefi, M. , Abbaspour-Aghdam, S. , Dolati, S. , Aghebati-Maleki, L. , Eghbal-Fard, S. , Khabbazi, A. , Rostamzadeh, D. , Alipour, S. , Shabani, M. , Nouri, M. , & Babaloo, Z. (2019). Disturbed Th17/Treg cell balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease. Journal of Cellular Physiology, 234(4), 3985-3994. https://doi.org/10.1002/jcp.27207"}, {"Citation": "Alipour, S. , Nouri, M. , Sakhinia, E. , Samadi, N. , Roshanravan, N. , Ghavami, A. , & Khabbazi, A. (2017). Epigenetic alterations in chronic disease focusing on Beh\u00e7et's disease. Biomedicine & Pharmacotherapy, 91, 526-533."}, {"Citation": "Aslani, S. , Jafari, N. , Javan, M. R. , Karami, J. , Ahmadi, M. , & Jafarnejad, M. (2017). Epigenetic modifications and therapy in multiple sclerosis. NeuroMolecular Medicine, 19(1), 11-23."}, {"Citation": "Aydos, T. R. , Ba\u015far, M. M. , Kul, O. , Atmaca, H. T. , Uzunali\u0307o\u011flu, T. , Kisa, \u00dc. , & Efe, O. E. (2014). Effects of ozone therapy and taurine on ischemia/reperfusion-induced testicular injury in a rat testicular torsion model. Turkish Journal of Medical Sciences, 44(5), 749-755."}, {"Citation": "Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116(2), 281-297."}, {"Citation": "Bartel, D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136(2), 215-233."}, {"Citation": "Bjerg, L. , Brosb\u00f8l-Ravnborg, A. , T\u00f8rring, C. , Dige, A. , Bundgaard, B. , Petersen, T. , & H\u00f6llsberg, P. (2012). Altered frequency of T regulatory cells is associated with disability status in relapsing-remitting multiple sclerosis patients. Journal of Neuroimmunology, 249(1-2), 76-82."}, {"Citation": "Bocci, V. A. (2006). Scientific and medical aspects of ozone therapy. State of the art. Archives of Medical Research, 37(4), 425-435."}, {"Citation": "Bocci, V. , Borrelli, E. , Travagli, V. , & Zanardi, I. (2009). The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Medicinal Research Reviews, 29(4), 646-682."}, {"Citation": "Bocci, V. , Zanardi, I. , & Travagli, V. (2011). Ozone: A new therapeutic agent in vascular diseases. American Journal of Cardiovascular Drugs, 11(2), 73-82."}, {"Citation": "Braidy, N. , Izadi, M. , Sureda, A. , Jonaidi-Jafari, N. , Banki, A. , Nabavi, S. F. , & Nabavi, S. M. (2018). Therapeutic relevance of ozone therapy in degenerative diseases: Focus on diabetes and spinal pain. Journal of Cellular Physiology, 233(4), 2705-2714. https://doi.org/10.1002/jcp.26044"}, {"Citation": "Braitch, M. , Harikrishnan, S. , Robins, R. , Nichols, C. , Fahey, A. , Showe, L. , & Constantinescu, C. (2009). Glucocorticoids increase CD4+ CD25high cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurologica Scandinavica, 119(4), 239-245."}, {"Citation": "Caglayan, S. , & Bayer, R. (1994). Effects of oxidative stress on erythrocyte deformability and fragility . Paper presented at the Quantification and Localization Using Diffuse Photons in a Highly Scattering Medium."}, {"Citation": "Compston, A. , & Coles, A. (2008). Multiple sclerosis. Lancet, 372(9648), 1502-1517."}, {"Citation": "Cong, H. , Jiang, H. , Peng, J. , Cui, S. , Liu, L. , Wang, J. , & Zhang, X. (2016). Change of Th17 lymphocytes and Treg cell/Th17 in typical and atypical optic neuritis. PLoS One, 11(1), e0146270."}, {"Citation": "Cruz, L. O. , Hashemifar, S. S. , Wu, C.-J. , Cho, S. , Nguyen, D. T. , Lin, L.-L. , Khan, A. A. , & Lu, L. F. (2017). Excessive expression of miR-27 impairs Treg cell-mediated immunological tolerance. The Journal of Clinical Investigation, 127(2), 530-542."}, {"Citation": "Danikowski, K. , Jayaraman, S. , & Prabhakar, B. (2017). Regulatory T cells in multiple sclerosis and myasthenia gravis. Journal of Neuroinflammation, 14(1), 117."}, {"Citation": "Dolati, S. , Aghebati-Maleki, L. , Ahmadi, M. , Marofi, F. , Babaloo, Z. , Ayramloo, H. , Jafarisavari, Z. , Oskouei, H. , Afkham, A. , Younesi, V. , Nouri, M. , & Yousefi, M. (2018). Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial. Journal of Cellular Physiology, 233(7), 5222-5230."}, {"Citation": "Dolati, S. , Ahmadi, M. , Aghebti-Maleki, L. , Nikmaram, A. , Marofi, F. , Rikhtegar, R. , Ayromlou, H. , & Yousefi, M. (2018). Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators. Pharmacological Reports, 70(6), 1158-1167."}, {"Citation": "Dolati, S. , Babaloo, Z. , Ayromlou, H. , Ahmadi, M. , Rikhtegar, R. , Rostamzadeh, D. , Roshangar, L. , Nouri, M. , Mehdizadeh, A. , Younesi, V. , & Yousefi, M. (2019). Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis. Journal of Neuroimmunology, 327, 15-21."}, {"Citation": "Eghbal-Fard, S. , Yousefi, M. , Heydarlou, H. , Ahmadi, M. , Taghavi, S. , Movasaghpour, A. , Jadidi-Niaragh, F. , Yousefi, B. , Dolati, S. , Hojjat-Farsangi, M. , Rikhtegar, R. , Nouri, M. , & Aghebati-Maleki, L. (2019). The imbalance of Th17/Treg cell axis involved in the pathogenesis of preeclampsia. Journal of Cellular Physiology, 234(4), 5106-5116. https://doi.org/10.1002/jcp.27315"}, {"Citation": "Elvis, A. , & Ekta, J. (2011). Ozone therapy: A clinical review. Journal of Natural Science, Biology, and Medicine, 2(1), 66."}, {"Citation": "Frohman, E. M. , Racke, M. K. , & Raine, C. S. (2006). Multiple sclerosis-The plaque and its pathogenesis. New England Journal of Medicine, 354(9), 942-955."}, {"Citation": "Ghasemi, N. , Razavi, S. , & Nikzad, E. (2017). Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy. Cell Journal, 19(1), 1-10."}, {"Citation": "Gregory, R. I. , Chendrimada, T. P. , Cooch, N. , & Shiekhattar, R. (2005). Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell, 123(4), 631-640."}, {"Citation": "Huan, J. , Culbertson, N. , Spencer, L. , Bartholomew, R. , Burrows, G. G. , Chou, Y. K. , Bourdette, D. , Ziegler, S. F. , Offner, H. , & Vandenbark, A. A. (2005). Decreased FOXP3 levels in multiple sclerosis patients. Journal of Neuroscience Research, 81(1), 45-52."}, {"Citation": "H\u00f8glund, R. A. , & Maghazachi, A. A. (2014). Multiple sclerosis and the role of immune cells. World Journal of Experimental Medicine, 4(3), 27."}, {"Citation": "Izadi, M. , Kheirjou, R. , Mohammadpour, R. , Aliyoldashi, M. H. , Moghadam, S. J. , Khorvash, F. , Jafari, N. J. , Shirvani, S. , & Khalili, N. (2019). Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing. Diabetes & Metabolic Syndrome, 13(1), 822-825."}, {"Citation": "Izadi, M. , Tahmasebi, S. , Pustokhina, I. , Yumashev, A. V. , Lakzaei, T. , Alvanegh, A. G. , Roshangar, L. , Dadashpour, M. , Yousefi, M. , & Ahmadi, M. (2020). Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients. Multiple Sclerosis and Related Disorders, 46, 102466."}, {"Citation": "Jamshidian, A. , Shaygannejad, V. , Pourazar, A. , Zarkesh-Esfahani, S.-H. , & Gharagozloo, M. (2013). Biased Treg cell/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms. Journal of Neuroimmunology, 262(1-2), 106-112."}, {"Citation": "Juchniewicz, H. , & Lubkowska, A. (2020). Oxygen-Ozone (O2-O3) therapy in peripheral arterial disease (PAD): A review study. Therapeutics and Clinical Risk Management, 16, 579-594. https://doi.org/10.2147/TCRM.S255247"}, {"Citation": "Kanwar, J. R. , Mahidhara, G. , & Kanwar, R. K. (2010). MicroRNA in human cancer and chronic inflammatory diseases. Frontiers in Bioscience, 2, 1113-1126."}, {"Citation": "Kaya, A. , Sonmez, M. , Kar, T. , Haholu, A. , Yildirim, Y. , M\u00fcft\u00fco\u011flu, T. , & \u00dcnal, M. H. (2017). Efficiency of ozone therapy in a rat model of experimental uveitis. Ocular Immunology and Inflammation, 25(5), 700-705."}, {"Citation": "Kulkarni, A. B. , Huh, C.-G. , Becker, D. , Geiser, A. , Lyght, M. , Flanders, K. C. , Roberts, A. B. , Sporn, M. B. , Ward, J. M. , & Karlsson, S. (1993). Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proceedings of the National Academy of Sciences of the United States of America, 90(2), 770-774."}, {"Citation": "Lee, P. W. , Severin, M. E. , & Lovett-Racke, A. E. (2017). TGF-\u03b2 regulation of encephalitogenic and regulatory T cells in multiple sclerosis. European Journal of Immunology, 47(3), 446-453."}, {"Citation": "Le\u00f3n, O. S. , Men\u00e9ndez, S. , Merino, N. , Castillo, R. , Sam, S. , P\u00e9rez, L. , Cruz, E. , & Bocci, V. (1998). Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators of Inflammation, 7(4), 289-294."}, {"Citation": "Li, Y. , Du, C. , Wang, W. , Ma, G. , Cui, L. , Zhou, H. , Tao, H. , Yao, L. , Zhao, B. , & Li, K. (2015). Genetic association of MiR-146a with multiple sclerosis susceptibility in the Chinese population. Cellular Physiology and Biochemistry, 35(1), 281-291."}, {"Citation": "Lintas, G. , Molinari, F. , Simonetti, V. , Franzini, M. , & Liboni, W. (2013). Time and time-frequency analysis of near-infrared signals for the assessment of ozone autohemotherapy long-term effects in multiple sclerosis. Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2013, 6171-6174."}, {"Citation": "Molinari, F. , Simonetti, V. , Franzini, M. , Pandolfi, S. , Vaiano, F. , Valdenassi, L. , & Liboni, W. (2014). Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients. International Journal of Immunopathology and Pharmacology, 27(3), 379-389."}, {"Citation": "Ozenci, V. , Kouwenhoven, M. , Huang, Y. , Xiao, B. , Kivisakk, P. , Fredrikson, S. , & Link, H. (1999). Multiple sclerosis: Levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-b-1b treatment. Scandinavian Journal of Immunology, 49(5), 554-561."}, {"Citation": "Pette, M. , Fujita, K. , Kitze, B. , Whitaker, J. , Albert, E. , Kappos, L. , & Wekerle, H. (1990). Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology, 40(11), 1770-1776."}, {"Citation": "Read, S. , Malmstr\u00f6m, V. , & Powrie, F. (2000). Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation. The Journal of Experimental Medicine, 192(2), 295-302."}, {"Citation": "Sakaguchi, S. , Fukuma, K. , Kuribayashi, K. , & Masuda, T. (1985). Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. The Journal of Experimental Medicine, 161(1), 72-87."}, {"Citation": "Sakaguchi, S. , Wing, K. , Onishi, Y. , Prieto-Martin, P. , & Yamaguchi, T. (2009). Regulatory T cells: how do they suppress immune responses? International Immunology, 21(10), 1105-1111."}, {"Citation": "Sakaguchi, S. , Yamaguchi, T. , Nomura, T. , & Ono, M. (2008). Regulatory T. cells and immune tolerance. cell, 133(5), 775-787."}, {"Citation": "Salem, N. A. , Assaf, N. , Ismail, M. F. , Khadrawy, Y. A. , & Samy, M. (2016). Ozone therapy in ethidium bromide-induced demyelination in rats: possible protective effect. Cellular and Molecular Neurobiology, 36(6), 943-954."}, {"Citation": "Scassellati, C. , Ciani, M. , Galoforo, A. C. , Zanardini, R. , Bonvicini, C. , & Geroldi, C. (2020). Molecular mechanisms in cognitive frailty: Potential therapeutic targets for oxygen-ozone treatment. Mechanisms of Ageing and Development, 186, 111210. https://doi.org/10.1016/j.mad.2020.111210"}, {"Citation": "Scassellati, C. , Galoforo, A. C. , Bonvicini, C. , Esposito, C. , & Ricevuti, G. (2020). Ozone: A natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing Research Reviews, 63, 101138. https://doi.org/10.1016/j.arr.2020.101138"}, {"Citation": "Shah, P. , Shyam, A. K. , & Shah, S. (2011). Adjuvant combined ozone therapy for extensive wound over tibia. Indian Journal of Orthopaedics, 45(4), 376."}, {"Citation": "Simonetti, V. , Liboni, W. , & Molinari, F. (2014). Why ozone therapy in multiple sclerosis? Ozone Therapy Global Journal, 4(1), 51-68."}, {"Citation": "Sonntag, K.-C. (2010). MicroRNAs and deregulated gene expression networks in neurodegeneration. Brain Research, 1338, 48-57."}, {"Citation": "Takahashi, T. , Tagami, T. , Yamazaki, S. , Uede, T. , Shimizu, J. , Sakaguchi, N. , Mak, T. W. , & Sakaguchi, S. (2000). Immunologic self-tolerance maintained by CD25+ CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. The Journal of Experimental Medicine, 192(2), 303-310."}, {"Citation": "Tufekci, K. U. , Oner, M. G. , Genc, S. , & Genc, K. (2011). MicroRNAs and multiple sclerosis. Autoimmune Diseases, 2011, 807426."}, {"Citation": "Tylicki, L. , Niew\u0229g\u0142owski, T. , Biedunkiewicz, B. , Burakowski, S. , & Rutkowski, B. (2001). Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs-pilot study. The International Journal of Artificial Organs, 24(2), 79-82."}, {"Citation": "Viebahn-H\u00e4nsler, R. , Le\u00f3n Fern\u00e1ndez, O. S. , & Fahmy, Z. (2012). Ozone in medicine: The low-dose ozone concept-Guidelines and treatment strategies. Ozone: Science & Engineering, 34(6), 408-424. https://doi.org/10.1080/01919512.2012.717847"}, {"Citation": "Viglietta, V. , Baecher-Allan, C. , Weiner, H. L. , & Hafler, D. A. (2004). Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. The Journal of Experimental Medicine, 199(7), 971-979."}, {"Citation": "Wang, J. , Ioan-Facsinay, A. , Van der Voort, E. I. , Huizinga, T. W. , & Toes, R. E. (2007). Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. European Journal of Immunology, 37(1), 129-138."}, {"Citation": "Yang, H.-Y. , Barbi, J. , Wu, C.-Y. , Zheng, Y. , Vignali, P. D. A. , Wu, X. , Tao, J. H. , Park, B. V. , Bandara, S. , Novack, L. , Ni, X. , Yang, X. , Chang, K. Y. , Wu, R. C. , Zhang, J. , Yang, C. W. , Pardoll, D. M. , Li, H. , & Pan, F. (2016). MicroRNA-17 modulates regulatory T cell function by targeting co-regulators of the Foxp3 transcription factor. Immunity, 45(1), 83-93."}, {"Citation": "Zanardi, I. , Borrelli, E. , Valacchi, G. , Travagli, V. , & Bocci, V. (2016). Ozone: A multifaceted molecule with unexpected therapeutic activity. Current Medicinal Chemistry, 23(4), 304-314."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2021", "Month": "3", "Day": "9"}, {"Year": "2021", "Month": "1", "Day": "29"}, {"Year": "2021", "Month": "3", "Day": "14"}, {"Year": "2021", "Month": "3", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "16", "Hour": "12", "Minute": "52"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33724614", "10.1002/cbin.11589"]}}], "PubmedBookArticle": []}